Transforming Healthcare
Strategic Advisory Services for Pharmaceutical Real-World Evidence
01. Insurance Claims Data Strategy
Navigating the insurance claims data landscape requires deep expertise in what’s available, what’s reliable, and what’s right for your specific research objectives. MEDDDICAL advises pharmaceutical companies on how to evaluate and leverage real-world evidence from claims data sources — helping you understand treatment patterns, patient outcomes, and the critical dimensions that separate adequate data from genuinely actionable intelligence.
02. Synthetic Patient Cohort Advisory
Synthetic patient cohorts are a powerful tool for pharmaceutical research — but only when designed with the right methodology and matched to your specific study requirements. MEDDDICAL guides companies through the considerations involved in commissioning and evaluating synthetic cohorts, helping you understand how simulated patient demographics can support efficacy and safety analyses, and what to look for when assessing the quality and applicability of these approaches to your drug development and market strategy goals.
03. AI-Powered Analytics Guidance
The analytics landscape has grown dramatically in sophistication — and complexity. MEDDDICAL helps pharmaceutical companies understand how AI-powered analytical capabilities can transform real-world data into actionable strategic intelligence. From evaluating predictive modelling approaches to identifying which analytical frameworks best serve your commercial objectives, we provide the expert guidance needed to navigate a market where capabilities range widely and the right choice depends heavily on your specific use case.
04. Market Access Strategy Consulting
Successful market access requires aligning real-world evidence with payer perspectives and patient needs — a process that demands both strategic clarity and deep familiarity with the data landscape. MEDDDICAL works alongside pharmaceutical companies to develop comprehensive market access strategies informed by robust real-world evidence frameworks. We help you ask the right questions, identify the right data approaches, and ensure your market entry strategy is built on intelligence that resonates with all key stakeholders.